Radiation Dose Monitoring Comprehensive Study by Type (Dosimeters, Area Process Monitors, Others), Application (Oncology, Cardiology, Orthopedic Applications, Others), Component (Software, Service), Modality (Radiography, Angiography, Mammography, Fluoroscopy & Interventional Imaging, Nuclear Medicine, Others), End User (Small Hospitals, Large Hospitals, Ambulatory Care Settings, Others) Players and Region - Global Market Outlook to 2025

Radiation Dose Monitoring Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Radiation Dose Monitoring Market?

Radiation dose monitoring is witnessed the highest growth rate in the upcoming years. Growth of the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose monitoring.

Highlights from Radiation Dose Monitoring Market Study
AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledGE Healthcare (United States), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), PACSHealth, LLC (United States), Bayer AG (Germany), Sectra AB (Sweden), Bracco Imaging S.p.A. (Italy) and Qaelum N.V. (Belgium)


The Players having a strong hold in the market are GE Healthcare, Philips Healthcare, Siemens Healthineers, and FUJIFILM Holdings Corporation. Research Analyst at AMA predicts that European and United States Players will contribute to the maximum growth of Global Radiation Dose Monitoring market throughout the forecasted period.

GE Healthcare (United States), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), PACSHealth, LLC (United States), Bayer AG (Germany), Sectra AB (Sweden), Bracco Imaging S.p.A. (Italy) and Qaelum N.V. (Belgium) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Agfa Healthcare (Belgium), Novarad Corporation (United States), Medic Vision (United States), Volpara Solutions Inc. (United States), Guerbet (France), Medsquare (France), Medic Vision (United States) and INFINITT Healthcare Co. Ltd. (South Korea).

Radiation Dose Monitoring Market Segmentation:
ScopeSub-Segments
Application / End UserOncology, Cardiology, Orthopedic Applications and Others
TypeDosimeters, Area Process Monitors and Others
ComponentSoftware,Service
ModalityRadiography,Angiography,Mammography,Fluoroscopy & Interventional Imaging,Nuclear Medicine,Others
End UserSmall Hospitals,Large Hospitals,Ambulatory Care Settings,Others


On the basis of geography, the market of Radiation Dose Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Installation Base of Radiology Equipment

Market Growth Drivers:
Rising use of Medical Imaging Technological Platforms such as X-Ray, Computed Tomography (Ct), Fluoroscopy and Nuclear Medicine and Growing Incidence of Chronic Diseases & Increasing Concerns over Radiation

Challenges:
Lack of Benchmarking for Dose Optimization across the Globe

Restraints:
Lack of Skilled Professionals

Opportunities:
Increasing Focus on Interventional Radiology and Nuclear Medicine

Key Target Audience
Radiation Dose Monitoring Providers, Potential Technology Investors, Research Organizations and Consulting Companies, Regulatory & Government Bodies, Downstream Vendors, End Users and Other

Recently, Medsquare has presented the latest innovations of its Patient Dose Management solution − Radiation Dose Monitor (RDM) − at the French Radiology Congress (JFR), from 11 – 14 October 2019 in Paris. This new version of RDM brings a certain number of improvements, notably related to the interface, functionalities and technicality of the product.


Report Objectives / Segmentation Covered

By Type
  • Dosimeters
  • Area Process Monitors
  • Others
By Application
  • Oncology
  • Cardiology
  • Orthopedic Applications
  • Others
By Component
  • Software
  • Service

By Modality
  • Radiography
  • Angiography
  • Mammography
  • Fluoroscopy & Interventional Imaging
  • Nuclear Medicine
  • Others

By End User
  • Small Hospitals
  • Large Hospitals
  • Ambulatory Care Settings
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising use of Medical Imaging Technological Platforms such as X-Ray, Computed Tomography (Ct), Fluoroscopy and Nuclear Medicine
      • 3.2.2. Growing Incidence of Chronic Diseases & Increasing Concerns over Radiation
    • 3.3. Market Challenges
      • 3.3.1. Lack of Benchmarking for Dose Optimization across the Globe
    • 3.4. Market Trends
      • 3.4.1. Growing Installation Base of Radiology Equipment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Radiation Dose Monitoring, by Type, Application, Component, Modality, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Radiation Dose Monitoring (Value)
      • 5.2.1. Global Radiation Dose Monitoring by: Type (Value)
        • 5.2.1.1. Dosimeters
        • 5.2.1.2. Area Process Monitors
        • 5.2.1.3. Others
      • 5.2.2. Global Radiation Dose Monitoring by: Application (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. Cardiology
        • 5.2.2.3. Orthopedic Applications
        • 5.2.2.4. Others
      • 5.2.3. Global Radiation Dose Monitoring by: Component (Value)
        • 5.2.3.1. Software
        • 5.2.3.2. Service
      • 5.2.4. Global Radiation Dose Monitoring by: Modality (Value)
        • 5.2.4.1. Radiography
        • 5.2.4.2. Angiography
        • 5.2.4.3. Mammography
        • 5.2.4.4. Fluoroscopy & Interventional Imaging
        • 5.2.4.5. Nuclear Medicine
        • 5.2.4.6. Others
      • 5.2.5. Global Radiation Dose Monitoring by: End User (Value)
        • 5.2.5.1. Small Hospitals
        • 5.2.5.2. Large Hospitals
        • 5.2.5.3. Ambulatory Care Settings
        • 5.2.5.4. Others
      • 5.2.6. Global Radiation Dose Monitoring Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Radiation Dose Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Philips Healthcare (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthineers (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. FUJIFILM Holdings Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Canon Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. PACSHealth, LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sectra AB (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bracco Imaging S.p.A. (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Qaelum N.V. (Belgium)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Radiation Dose Monitoring Sale, by Type, Application, Component, Modality, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Radiation Dose Monitoring (Value)
      • 7.2.1. Global Radiation Dose Monitoring by: Type (Value)
        • 7.2.1.1. Dosimeters
        • 7.2.1.2. Area Process Monitors
        • 7.2.1.3. Others
      • 7.2.2. Global Radiation Dose Monitoring by: Application (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. Cardiology
        • 7.2.2.3. Orthopedic Applications
        • 7.2.2.4. Others
      • 7.2.3. Global Radiation Dose Monitoring by: Component (Value)
        • 7.2.3.1. Software
        • 7.2.3.2. Service
      • 7.2.4. Global Radiation Dose Monitoring by: Modality (Value)
        • 7.2.4.1. Radiography
        • 7.2.4.2. Angiography
        • 7.2.4.3. Mammography
        • 7.2.4.4. Fluoroscopy & Interventional Imaging
        • 7.2.4.5. Nuclear Medicine
        • 7.2.4.6. Others
      • 7.2.5. Global Radiation Dose Monitoring by: End User (Value)
        • 7.2.5.1. Small Hospitals
        • 7.2.5.2. Large Hospitals
        • 7.2.5.3. Ambulatory Care Settings
        • 7.2.5.4. Others
      • 7.2.6. Global Radiation Dose Monitoring Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Radiation Dose Monitoring: by Type(USD Million)
  • Table 2. Radiation Dose Monitoring Dosimeters , by Region USD Million (2016-2021)
  • Table 3. Radiation Dose Monitoring Area Process Monitors , by Region USD Million (2016-2021)
  • Table 4. Radiation Dose Monitoring Others , by Region USD Million (2016-2021)
  • Table 5. Radiation Dose Monitoring: by Application(USD Million)
  • Table 6. Radiation Dose Monitoring Oncology , by Region USD Million (2016-2021)
  • Table 7. Radiation Dose Monitoring Cardiology , by Region USD Million (2016-2021)
  • Table 8. Radiation Dose Monitoring Orthopedic Applications , by Region USD Million (2016-2021)
  • Table 9. Radiation Dose Monitoring Others , by Region USD Million (2016-2021)
  • Table 10. Radiation Dose Monitoring: by Component(USD Million)
  • Table 11. Radiation Dose Monitoring Software , by Region USD Million (2016-2021)
  • Table 12. Radiation Dose Monitoring Service , by Region USD Million (2016-2021)
  • Table 13. Radiation Dose Monitoring: by Modality(USD Million)
  • Table 14. Radiation Dose Monitoring Radiography , by Region USD Million (2016-2021)
  • Table 15. Radiation Dose Monitoring Angiography , by Region USD Million (2016-2021)
  • Table 16. Radiation Dose Monitoring Mammography , by Region USD Million (2016-2021)
  • Table 17. Radiation Dose Monitoring Fluoroscopy & Interventional Imaging , by Region USD Million (2016-2021)
  • Table 18. Radiation Dose Monitoring Nuclear Medicine , by Region USD Million (2016-2021)
  • Table 19. Radiation Dose Monitoring Others , by Region USD Million (2016-2021)
  • Table 20. Radiation Dose Monitoring: by End User(USD Million)
  • Table 21. Radiation Dose Monitoring Small Hospitals , by Region USD Million (2016-2021)
  • Table 22. Radiation Dose Monitoring Large Hospitals , by Region USD Million (2016-2021)
  • Table 23. Radiation Dose Monitoring Ambulatory Care Settings , by Region USD Million (2016-2021)
  • Table 24. Radiation Dose Monitoring Others , by Region USD Million (2016-2021)
  • Table 25. South America Radiation Dose Monitoring, by Country USD Million (2016-2021)
  • Table 26. South America Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 27. South America Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 28. South America Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 29. South America Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 30. South America Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 31. Brazil Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 32. Brazil Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 33. Brazil Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 34. Brazil Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 35. Brazil Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 36. Argentina Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 37. Argentina Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 38. Argentina Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 39. Argentina Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 40. Argentina Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 41. Rest of South America Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 42. Rest of South America Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 43. Rest of South America Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 44. Rest of South America Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 45. Rest of South America Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 46. Asia Pacific Radiation Dose Monitoring, by Country USD Million (2016-2021)
  • Table 47. Asia Pacific Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 48. Asia Pacific Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 49. Asia Pacific Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 50. Asia Pacific Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 51. Asia Pacific Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 52. China Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 53. China Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 54. China Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 55. China Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 56. China Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 57. Japan Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 58. Japan Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 59. Japan Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 60. Japan Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 61. Japan Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 62. India Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 63. India Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 64. India Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 65. India Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 66. India Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 67. South Korea Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 68. South Korea Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 69. South Korea Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 70. South Korea Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 71. South Korea Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 72. Taiwan Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 73. Taiwan Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 74. Taiwan Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 75. Taiwan Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 76. Taiwan Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 77. Australia Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 78. Australia Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 79. Australia Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 80. Australia Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 81. Australia Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 85. Rest of Asia-Pacific Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 86. Rest of Asia-Pacific Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 87. Europe Radiation Dose Monitoring, by Country USD Million (2016-2021)
  • Table 88. Europe Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 89. Europe Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 90. Europe Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 91. Europe Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 92. Europe Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 93. Germany Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 94. Germany Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 95. Germany Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 96. Germany Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 97. Germany Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 98. France Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 99. France Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 100. France Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 101. France Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 102. France Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 103. Italy Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 104. Italy Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 105. Italy Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 106. Italy Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 107. Italy Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 108. United Kingdom Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 109. United Kingdom Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 110. United Kingdom Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 111. United Kingdom Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 112. United Kingdom Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 113. Netherlands Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 114. Netherlands Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 115. Netherlands Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 116. Netherlands Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 117. Netherlands Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 118. Rest of Europe Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 119. Rest of Europe Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 120. Rest of Europe Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 121. Rest of Europe Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 122. Rest of Europe Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 123. MEA Radiation Dose Monitoring, by Country USD Million (2016-2021)
  • Table 124. MEA Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 125. MEA Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 126. MEA Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 127. MEA Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 128. MEA Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 129. Middle East Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 130. Middle East Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 131. Middle East Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 132. Middle East Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 133. Middle East Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 134. Africa Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 135. Africa Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 136. Africa Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 137. Africa Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 138. Africa Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 139. North America Radiation Dose Monitoring, by Country USD Million (2016-2021)
  • Table 140. North America Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 141. North America Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 142. North America Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 143. North America Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 144. North America Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 145. United States Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 146. United States Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 147. United States Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 148. United States Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 149. United States Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 150. Canada Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 151. Canada Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 152. Canada Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 153. Canada Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 154. Canada Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 155. Mexico Radiation Dose Monitoring, by Type USD Million (2016-2021)
  • Table 156. Mexico Radiation Dose Monitoring, by Application USD Million (2016-2021)
  • Table 157. Mexico Radiation Dose Monitoring, by Component USD Million (2016-2021)
  • Table 158. Mexico Radiation Dose Monitoring, by Modality USD Million (2016-2021)
  • Table 159. Mexico Radiation Dose Monitoring, by End User USD Million (2016-2021)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Radiation Dose Monitoring: by Type(USD Million)
  • Table 171. Radiation Dose Monitoring Dosimeters , by Region USD Million (2022-2027)
  • Table 172. Radiation Dose Monitoring Area Process Monitors , by Region USD Million (2022-2027)
  • Table 173. Radiation Dose Monitoring Others , by Region USD Million (2022-2027)
  • Table 174. Radiation Dose Monitoring: by Application(USD Million)
  • Table 175. Radiation Dose Monitoring Oncology , by Region USD Million (2022-2027)
  • Table 176. Radiation Dose Monitoring Cardiology , by Region USD Million (2022-2027)
  • Table 177. Radiation Dose Monitoring Orthopedic Applications , by Region USD Million (2022-2027)
  • Table 178. Radiation Dose Monitoring Others , by Region USD Million (2022-2027)
  • Table 179. Radiation Dose Monitoring: by Component(USD Million)
  • Table 180. Radiation Dose Monitoring Software , by Region USD Million (2022-2027)
  • Table 181. Radiation Dose Monitoring Service , by Region USD Million (2022-2027)
  • Table 182. Radiation Dose Monitoring: by Modality(USD Million)
  • Table 183. Radiation Dose Monitoring Radiography , by Region USD Million (2022-2027)
  • Table 184. Radiation Dose Monitoring Angiography , by Region USD Million (2022-2027)
  • Table 185. Radiation Dose Monitoring Mammography , by Region USD Million (2022-2027)
  • Table 186. Radiation Dose Monitoring Fluoroscopy & Interventional Imaging , by Region USD Million (2022-2027)
  • Table 187. Radiation Dose Monitoring Nuclear Medicine , by Region USD Million (2022-2027)
  • Table 188. Radiation Dose Monitoring Others , by Region USD Million (2022-2027)
  • Table 189. Radiation Dose Monitoring: by End User(USD Million)
  • Table 190. Radiation Dose Monitoring Small Hospitals , by Region USD Million (2022-2027)
  • Table 191. Radiation Dose Monitoring Large Hospitals , by Region USD Million (2022-2027)
  • Table 192. Radiation Dose Monitoring Ambulatory Care Settings , by Region USD Million (2022-2027)
  • Table 193. Radiation Dose Monitoring Others , by Region USD Million (2022-2027)
  • Table 194. South America Radiation Dose Monitoring, by Country USD Million (2022-2027)
  • Table 195. South America Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 196. South America Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 197. South America Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 198. South America Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 199. South America Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 200. Brazil Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 201. Brazil Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 202. Brazil Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 203. Brazil Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 204. Brazil Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 205. Argentina Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 206. Argentina Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 207. Argentina Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 208. Argentina Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 209. Argentina Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 210. Rest of South America Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 211. Rest of South America Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 212. Rest of South America Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 213. Rest of South America Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 214. Rest of South America Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 215. Asia Pacific Radiation Dose Monitoring, by Country USD Million (2022-2027)
  • Table 216. Asia Pacific Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 217. Asia Pacific Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 218. Asia Pacific Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 219. Asia Pacific Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 220. Asia Pacific Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 221. China Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 222. China Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 223. China Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 224. China Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 225. China Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 226. Japan Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 227. Japan Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 228. Japan Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 229. Japan Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 230. Japan Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 231. India Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 232. India Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 233. India Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 234. India Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 235. India Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 236. South Korea Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 237. South Korea Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 238. South Korea Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 239. South Korea Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 240. South Korea Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 241. Taiwan Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 242. Taiwan Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 243. Taiwan Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 244. Taiwan Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 245. Taiwan Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 246. Australia Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 247. Australia Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 248. Australia Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 249. Australia Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 250. Australia Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 251. Rest of Asia-Pacific Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 253. Rest of Asia-Pacific Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 254. Rest of Asia-Pacific Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 255. Rest of Asia-Pacific Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 256. Europe Radiation Dose Monitoring, by Country USD Million (2022-2027)
  • Table 257. Europe Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 258. Europe Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 259. Europe Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 260. Europe Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 261. Europe Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 262. Germany Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 263. Germany Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 264. Germany Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 265. Germany Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 266. Germany Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 267. France Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 268. France Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 269. France Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 270. France Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 271. France Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 272. Italy Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 273. Italy Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 274. Italy Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 275. Italy Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 276. Italy Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 277. United Kingdom Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 278. United Kingdom Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 279. United Kingdom Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 280. United Kingdom Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 281. United Kingdom Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 282. Netherlands Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 283. Netherlands Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 284. Netherlands Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 285. Netherlands Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 286. Netherlands Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 287. Rest of Europe Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 288. Rest of Europe Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 289. Rest of Europe Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 290. Rest of Europe Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 291. Rest of Europe Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 292. MEA Radiation Dose Monitoring, by Country USD Million (2022-2027)
  • Table 293. MEA Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 294. MEA Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 295. MEA Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 296. MEA Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 297. MEA Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 298. Middle East Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 299. Middle East Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 300. Middle East Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 301. Middle East Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 302. Middle East Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 303. Africa Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 304. Africa Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 305. Africa Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 306. Africa Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 307. Africa Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 308. North America Radiation Dose Monitoring, by Country USD Million (2022-2027)
  • Table 309. North America Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 310. North America Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 311. North America Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 312. North America Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 313. North America Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 314. United States Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 315. United States Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 316. United States Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 317. United States Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 318. United States Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 319. Canada Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 320. Canada Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 321. Canada Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 322. Canada Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 323. Canada Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 324. Mexico Radiation Dose Monitoring, by Type USD Million (2022-2027)
  • Table 325. Mexico Radiation Dose Monitoring, by Application USD Million (2022-2027)
  • Table 326. Mexico Radiation Dose Monitoring, by Component USD Million (2022-2027)
  • Table 327. Mexico Radiation Dose Monitoring, by Modality USD Million (2022-2027)
  • Table 328. Mexico Radiation Dose Monitoring, by End User USD Million (2022-2027)
  • Table 329. Research Programs/Design for This Report
  • Table 330. Key Data Information from Secondary Sources
  • Table 331. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Radiation Dose Monitoring: by Type USD Million (2016-2021)
  • Figure 5. Global Radiation Dose Monitoring: by Application USD Million (2016-2021)
  • Figure 6. Global Radiation Dose Monitoring: by Component USD Million (2016-2021)
  • Figure 7. Global Radiation Dose Monitoring: by Modality USD Million (2016-2021)
  • Figure 8. Global Radiation Dose Monitoring: by End User USD Million (2016-2021)
  • Figure 9. South America Radiation Dose Monitoring Share (%), by Country
  • Figure 10. Asia Pacific Radiation Dose Monitoring Share (%), by Country
  • Figure 11. Europe Radiation Dose Monitoring Share (%), by Country
  • Figure 12. MEA Radiation Dose Monitoring Share (%), by Country
  • Figure 13. North America Radiation Dose Monitoring Share (%), by Country
  • Figure 14. Global Radiation Dose Monitoring share by Players 2021 (%)
  • Figure 15. Global Radiation Dose Monitoring share by Players (Top 3) 2021(%)
  • Figure 16. Global Radiation Dose Monitoring share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 19. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 20. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 21. Philips Healthcare (Netherlands) Revenue: by Geography 2021
  • Figure 22. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Siemens Healthineers (Germany) Revenue: by Geography 2021
  • Figure 24. FUJIFILM Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 25. FUJIFILM Holdings Corporation (Japan) Revenue: by Geography 2021
  • Figure 26. Canon Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Canon Inc. (Japan) Revenue: by Geography 2021
  • Figure 28. PACSHealth, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. PACSHealth, LLC (United States) Revenue: by Geography 2021
  • Figure 30. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 32. Sectra AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 33. Sectra AB (Sweden) Revenue: by Geography 2021
  • Figure 34. Bracco Imaging S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 35. Bracco Imaging S.p.A. (Italy) Revenue: by Geography 2021
  • Figure 36. Qaelum N.V. (Belgium) Revenue, Net Income and Gross profit
  • Figure 37. Qaelum N.V. (Belgium) Revenue: by Geography 2021
  • Figure 38. Global Radiation Dose Monitoring: by Type USD Million (2022-2027)
  • Figure 39. Global Radiation Dose Monitoring: by Application USD Million (2022-2027)
  • Figure 40. Global Radiation Dose Monitoring: by Component USD Million (2022-2027)
  • Figure 41. Global Radiation Dose Monitoring: by Modality USD Million (2022-2027)
  • Figure 42. Global Radiation Dose Monitoring: by End User USD Million (2022-2027)
  • Figure 43. South America Radiation Dose Monitoring Share (%), by Country
  • Figure 44. Asia Pacific Radiation Dose Monitoring Share (%), by Country
  • Figure 45. Europe Radiation Dose Monitoring Share (%), by Country
  • Figure 46. MEA Radiation Dose Monitoring Share (%), by Country
  • Figure 47. North America Radiation Dose Monitoring Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Philips Healthcare (Netherlands)
  • Siemens Healthineers (Germany)
  • FUJIFILM Holdings Corporation (Japan)
  • Canon Inc. (Japan)
  • PACSHealth, LLC (United States)
  • Bayer AG (Germany)
  • Sectra AB (Sweden)
  • Bracco Imaging S.p.A. (Italy)
  • Qaelum N.V. (Belgium)
Additional players considered in the study are as follows:
Agfa Healthcare (Belgium) , Novarad Corporation (United States) , Medic Vision (United States) , Volpara Solutions Inc. (United States) , Guerbet (France) , Medsquare (France) , Medic Vision (United States) , INFINITT Healthcare Co. Ltd. (South Korea)
Select User Access Type

Key Highlights of Report


Oct 2020 234 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rising use of Medical Imaging Technological Platforms such as X-Ray, Computed Tomography (Ct), Fluoroscopy and Nuclear Medicine " is seen as one of major growth factors of Radiation Dose Monitoring Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Radiation Dose Monitoring market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Radiation Dose Monitoring Market Report?